Page last updated: 2024-10-23

bisindolylmaleimide i and Heart Failure

bisindolylmaleimide i has been researched along with Heart Failure in 2 studies

bisindolylmaleimide I: a bis(indolyl)maleimide

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saad, NS1
Elnakish, MT1
Brundage, EA1
Biesiadecki, BJ1
Kilic, A1
Ahmed, AAE1
Mohler, PJ1
Janssen, PML1
Guo, J1
Sabri, A1
Elouardighi, H1
Rybin, V1
Steinberg, SF1

Other Studies

2 other studies available for bisindolylmaleimide i and Heart Failure

ArticleYear
Assessment of PKA and PKC inhibitors on force and kinetics of non-failing and failing human myocardium.
    Life sciences, 2018, Dec-15, Volume: 215

    Topics: Adult; Aged; Cyclic AMP-Dependent Protein Kinases; Female; Heart; Heart Failure; Heart Ventricles; H

2018
Alpha1-adrenergic receptors activate AKT via a Pyk2/PDK-1 pathway that is tonically inhibited by novel protein kinase C isoforms in cardiomyocytes.
    Circulation research, 2006, Dec-08, Volume: 99, Issue:12

    Topics: Animals; Apoptosis; Cardiomegaly; Cells, Cultured; Enzyme Inhibitors; Focal Adhesion Kinase 2; Gene

2006